跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Batimastat
首页
药物
Batimastat
Experimental
Small Molecule
Batimastat
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
化学式
C
23
H
31
N
3
O
4
S
2
CAS 编号
130370-60-4
UNII ID
BK349F52C9
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Drug delivery from stents
申请人: ABBOTT LAB
优先权: 2001
US
8 件公开
Method of treating fatty liver disease
申请人: CHILDRENS MEDICAL CENTER
优先权: 2006
US
2 件公开
METHODS FOR DIAGNOSING AND TREATING ALZHEIMER'S DISEASE BY ADMINISTERING AN ANGIOGENIC AGENT
申请人: JEFFERIES DR WILFRED
优先权: 2011
EP
2 件公开
Methods and compositions for treating and inhibiting retinal neovascularization
申请人: INSITE VISION INC
优先权: 2000
US
Cosmetic Composition and Method
申请人: QUICK MED TECHNOLOGIES INC
优先权: 2006
US
Osteogenic regenerative scaffold matrix composition
申请人: ELAZIZI MOHAMAD
优先权: 2015
US
Polyester-polyether temperature-sensitive gel with slow release of batimastat and preparation method thereof
申请人: UNIV CHINA PHARMA
优先权: 2017
CN
Early management, mitigation and prevention of sepsis and sepsis-like syndromes, including neo-natal ARDS due to infection, injury or iatrogenesis
申请人: OPHIREX INC
优先权: 2022
US
药物
反馈